Maggie Throup: No recent assessment has been made. In 2021/22 the national Public Health Grant to local authorities in England is £3.234 billion. The Grant supports the delivery of their public health functions, including contraceptive services. It is for individual local authorities to determine how funding is spent to meet local population health needs.
Maggie Throup: The Office for Health Improvement and Disparities (OHID) will be established on 1 October 2021. The OHID will develop a new Sexual and Reproductive Health Strategy planned for publication later this year and will consider issues related to women’s sexual and reproductive healthcare, including addressing the unmet need for contraception.
Maggie Throup: The Department is currently in the process of drafting the new Tobacco Control Plan working closely with Public Health England and other Government departments. We expect the final Tobacco Control Plan to be published by the end of the year.
Maggie Throup: As of 1 September 2021, there were 1,707 consultants in NHS Test and Trace. We are unable to provide information on the average cost of consultants as this is commercially sensitive.
Maggie Throup: The information is not held in the format requested.
Maggie Throup: There have been no specific recent discussions.
Maggie Throup: We are continuing with an extended flu vaccination programme for the 2021/22 flu season and over 35 million people will be eligible for a free seasonal flu vaccine. This year includes a continued offer of vaccination for 50 to 64 year olds, and the programme is being extended to additional cohorts in secondary school to help prevent disease transmission. The National Health Service continues...
Maggie Throup: Work is ongoing to determine which non-United Kingdom vaccines we might be confident to recognise, including those administered in Saudi Arabia. A pilot scheme to enable some UK residents vaccinated overseas to demonstrate their vaccination status through the NHS COVID Pass will be launched in England from the end of September. Further development will be undertaken once the pilot is underway.
Maggie Throup: Vaccination events not recorded within one of the English vaccination programme point of care solutions do not appear in the national vaccination database. In line with the development of the overseas vaccination service, general practitioners (GPs) will be directed to refer patients to this service that will be available at a number of English vaccination sites from October. This will...
Maggie Throup: Decisions to place countries on the ‘red list’ are taken by the Government, informed by evidence including the Joint Biosecurity Centre risk assessments alongside other factors. We are unable to provide the information requested as the advice, evidence and methodology that informs these decisions relates to on-going development of Government policy. However, further information on the...
Maggie Throup: The shielding programme has now ended in England. People who were previously considered clinically extremely vulnerable will not be advised to shield or follow specific national guidance. The same guidance for the general population should now be followed. Those who remain concerned should discuss any risks with their National Health Service clinician.
Maggie Throup: The Department has robust plans for responding to disease outbreaks that are regularly tested through preparedness exercises and we recognise the public interest in making this information available. Exercise Alice tested preparedness for handling an outbreak of Middle Eastern Respiratory Syndrome (MERS-CoV). As both MERS and COVID-19 are caused by coronaviruses, the Department assesses that...
Maggie Throup: We have made resources on supported conversations available, including webinars and communications to address the concerns of those who may be hesitant to receive the vaccine. The ‘Coronavirus (COVID-19) vaccination of people working or deployed in care homes: operational guidance’ includes a toolkit which can be used to support conversations with trusted peers or medical professionals.
Maggie Throup: Experts continue to keep the symptoms under review as our understanding of the virus develops. We assess the data from the COVID Symptom Study in addition to other surveillance studies and will update our guidance if necessary.
Maggie Throup: The shielding programme has now ended in England, meaning that people who were previously considered clinically extremely vulnerable will not be advised to shield in the future or follow specific national guidance. The same general guidance for the whole population should now be followed. Those who remain concerned should discuss any risks their National Health Service clinician.
Maggie Throup: The Government has entered into an agreement with GlaxoSmithKline for the procurement of 100,008 doses of sotrovimab. This procurement is subject to independent approval of sotrovimab by the Medicines and Healthcare products Regulatory Agency who will assess the medicine for safety and efficacy for treatment of COVID-19.
Maggie Throup: We have monitored company trials and development of a number of antivirals including Pfizer’s PF-07321332/Ritonavir but are not funding development. We are in contact with a number of manufacturers to ensure that United Kingdom patients have access to COVID-19 antivirals as evidence emerges.
Maggie Throup: We are monitoring clinical trials and development of monoclonal antibodies including Ronapreve, Sotrovimab and AZD7442. Ronapreve was part of the Government supported RECOVERY trial and in August the Medicines and althcare products Regulatory Agency approved Ronapreve as the first neutralising monoclonal antibody combination product for use in the prevention and treatment of COVID-19 in the...
Maggie Throup: The adult social care workforce has a higher percentage of women and people from ethnically diverse communities and evidence shows that people in these groups are more likely to be hesitant about taking the COVID-19 vaccine. The reasons for hesitancy in these groups could include lack of knowledge about the vaccine, misinformation and perceptions of equality and discrimination. There is...
Maggie Throup: Following technical discussions with the European Union, we have now applied to join the EU’s Digital COVID Certificate scheme. This will enable digital verification of COVID-19 certification. In the meantime, passengers can continue to demonstrate their status via physical checks.